Combining Biochemisty, Physiology, Microbiology, Ecology, Evolutionary Biology, Writing, Mathematics, Computers, Teaching, Music, History, Athletics, Craftsmanship, and Art to Make the World a Better Place ☺
Web sites and pages:
Bacteriophage Ecology Group (phage.org)
BEG page revision, draft (archaealviruses.org)
Biology as Poetry (biologyaspoetry.com)
Bacteriophage Glossary (archaealviruses.org/terms/)
International Society for Viruses of Microorganisms (ISVM.org)
Phage Therapy (phage-therapy.org)
The Bacteriophages 2/e (thebacteriophages.org)
OSU Microbiology (base page)
Monographs and edited volumes:
Bacteriophages in Health and Disease (edited volume)
Bacteriophages and Biofilms 1/e (book version)
The 'Nuts and Bolts' of Phage Therapy (86 pp journal vol; contact Steve)
Bacteriophage Ecology (edited volume)
The Bacteriophages 2/e (edited volume)
Other:
Amazon Author's Page
Google Scholar
Curriculum vitae
Unabridged CV with links to pubs (contact me for password)
Phage monographs
Bacteriophage (journal)
Phage attack t-shirts (thebacteriophages.com/sales.htm)
Open-access publications:
Abedon, S. T. 2012. Spatial vulnerability: bacterial arrangements, microcolonies, and biofilms as responses to low rather than high phage densities. Viruses. 4:663-687 [publisher]
Abedon, S. T. 2012. Bacterial 'immunity' against bacteriophages. Bacteriophage 2. [publisher]
Abedon, S. T. 2011. Lysis from without. Bacteriophage 1:46-49. [PubMed]
Abedon, S. T. 2011. Facilitation of CRISPR adaptation. Bacteriophage 1:179-181. [PubMed]
Abedon, S. T., S. J. Kuhl, B. G. Blasdel, and E. M. Kutter. 2011. Phage treatment of human infections. Bacteriophage 1:66-85. [publisher]
Abedon, S. T., C. Thomas-Abedon, A. Thomas, and H. Mazure 2011. Bacteriophage prehistory: Is or is not Hankin, 1896, a phage reference? 1:174-178. [PubMed]
Curtright, A. J. and S. T. Abedon. 2011. Phage therapy: emergent property pharmacology. J.Bioanal.Biomed. S6. [preprint (search for "abedon")]
Loc-Carrillo, C. and S. T. Abedon. 2011. Pros and cons of phage therapy. Bacteriophage 1:111-114. [publisher]
Abedon, S. T.. 2010. The 'nuts and bolts' of phage therapy. Curr.Pharm.Biotechnol. 11:1. [publisher]
Abedon, S. T.. 2010. Bacteriophages and biofilms, p. 1-58. In: W. C. Bailey (ed.), Biofilms: Formation, Development and Properties. Nova Science Publishers, Hauppauge, New York. [publisher]
Abedon, S. T. and C. Thomas-Abedon. 2010. Phage therapy pharmacology. Curr.Pharm.Biotechnol. 11:28-47. [PubMed; click on link to publisher page, i.e., Bentham Direct, then click "View", and then click on "Full Text"; finally, click on "Download"]
Kutter, E., D. De Vos, G. Gvasalia, Z. Alavidze, L. Gogokhia, S. Kuhl, and S. T. Abedon. 2010. Phage therapy in clinical practice: treatment of human infections. Curr.Pharm.Biotechnol. 11:69-86. [PubMed; click on link to publisher page, i.e., Bentham Direct, then click "View", and then click on "Full Text"; finally, click on "Download"]
Abedon, S. T. and J. T. LeJeune. 2005. Why bacteriophage encode exotoxins and other virulence factors. 1:97-110. [PubMed]
Abedon, S. T., P. Hyman, and C. Thomas. 2003. Experimental examination of bacteriophage latent-period evolution as a response to bacterial availability. 69:7499-7506. [PubMed]
Abedon, S. T., T. D. Herschler, and D. Stopar. 2001. Bacteriophage latent-period evolution as a response to resource availability. 67:4233-4241. [PubMed]
Abedon, S. T.. 2000. The murky origin of Snow White and her T-even dwarfs. 155:481-486. [PubMed]
Paddison, P., S. T. Abedon, H. K. Dressman, K. Gailbreath, J. Tracy, E. Mosser, J. Neitzel, B. Guttman, E. Kutter. 1998. The roles of the bacteriophage T4 r genes in lysis inhibition and fine-structure genetics: a new perspective. 148:1539-1550. [PubMed]
Abedon, S. T.. 1992. Lysis of lysis-inhibited bacteriophage T4-infected cells. 174:8073-8080. [PubMed]
About:
Steve Abedon is an Associate Professor of Microbiology at The Ohio State University, where he has served on the faculty, primarily as an instructor of undergraduates, since 1995. His principal research interest is in the evolutionary ecology of bacteriophages, a.k.a., phages, which are Earth's most prevalent category of viruses, while viruses are Earth's most abundant category of 'organisms'. This interest he pursues from both basic science and applied perspectives, organismal evolutionary adaptation and the use of phages as 'antibiotics' – phage therapy – respectively. He sees the core of his scientific training as being in biochemistry, having received his BS in that subject, but overlain with a strong tendency to explore issues of organism-level phenotype and ultimate causation.
In the ~20 years since receiving his Ph.D. – in Microbiology with a minor in Ecology and Evolutionary Biology (University of Arizona, 1990) – he has published over 70 articles, chapters, and other 'citable units'. The latter includes involvement in the editing of four volumes, one as contributing editor ("with editorial assistance by...", The Bacteriophages 2/e, 2006, Oxford University Press), one as sole editor (Bacteriophage Ecology, 2008, Cambridge University Press), one as co-editor (Human and Abedon, Bacteriophages in Health and Disease, in production, CABI Press, and one as editor of a special topics issue of the journal Current Pharmaceutical Biotechnology (The 'Nuts and Bolts' of Phage Therapy, 2010, Bentham Scientific). He has also written one book (Bacteriophages and Biofilms, 2011, Nova Scientific), has fully drafted two textbooks (Microbes and Evolution and Biology as Poetry). In addition, he founded, in 1996, the Bacteriophage Ecology Group (phage.org), an ensemble of all things phage ecological. In his spare time he cooks (Schezuan Chinese-inspired), tends to his family (two children and loving wife), takes care of his 'farm' (when there isn't any snow about), and otherwise skis as much as possible.
Contact Steve.
